hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukaemia 2

Published: 10 August 2022| Version 1 | DOI: 10.17632/zmgy6sgxbh.1
Contributors:
Deepali Pal, Helen Blair, Sirintra Nakjang

Description

WES data

Files

Categories

Exome Sequencing

Licence